Page 251 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 251
230 PART III Therapeutic Modalities for the Cancer Patient
239. Pack L, Roberts RE, Dawson SD, et al.: Definitive radiation ther- 243. Fuccio L, Guido A, Laterza L, et al.: Randomised clinical trial: pre-
apy for infiltrative thyroid carcinoma in dogs, Vet Radiol Ultrasound ventive treatment with topical rectal beclomethasone dipropionate
42:471–474, 2001. reduces post-radiation risk of bleeding in patients irradiated for
VetBooks.ir 240. Ohara K, Tatsuzaki H, Fuji H, et al.: Radioresponse of thymomas 244. Magestro LM, Gieger TL, Nolan MW: Stereotactic body radiation
prostate cancer, Aliment Pharmacol Ther 34:628–637, 2011.
verified with histologic response, Acta Oncol 37:471–474, 1998.
241. Smith AN, Wright JC, Brawner Jr WR, et al.: Radiation therapy in
197, 2018.
the treatment of canine and feline thymomas: a retrospective study therapy for heart-base tumors in six dogs, J Vet Cardiol 20:186–
(1985-1999), J Am Anim Hosp Assoc 37:489–496, 2001.
242. Meier V, Besserer J, Roos M, et al.: A complication probability
study for a definitive-intent, moderately hypofractionated image-
guided intensity-modulated radiotherapy protocol for anal sac ade-
nocarcinoma in dogs, Vet Comp Oncol 218; epub ahead of print.
DOI: 10.1111/vco.12441